Efficacy, renal safety and tolerability of sodium-glucose cotransporter 2 inhibitors (SGLT2i) in elderly patients with type 2 diabetes: A real-world experience
• Older patients with T2DM are often excluded from randomized controlled trials. • The insulin-independent mechanism of action makes SGLT2i suitable in the elderly. • Our study focused on SGLT2i-treated older patients with T2DM, stratified by age (65–69 and ≥70 years). • HbA1c reduction, eGFR variat...
Description complète
Détails bibliographiques
| Publié dans: | A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients. - 2016. - Amsterdam [u.a.]
|
|---|
| Auteur principal: |
Tumminia, Andrea
(Auteur) |
|---|
| Autres auteurs: |
Graziano, Marco
(Autre),
Vinciguerra, Federica
(Autre),
Lomonaco, Andrea
(Autre),
Frittita, Lucia
(Autre) |
|---|
| Format: | Article en ligne
|
|---|
| Langue: | English |
|---|
| Publié: |
2021
|
|---|
| Accès à la collection: | A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients
|
|---|
| Sujets: | Type 2 diabetes
Elderly
Sodium-glucose cotransporter 2 inhibitors
Real-world evidence |
|---|
| Description matérielle: | 6 |
|---|